This is a preview of subscription content, log in via an institution to check access.
Reference
Kwiatkowski J, et al. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function. Pharmacology 106: 316-322, No. 5, May 2021. Available from: URL: http://doi.org/10.1159/000513377
Rights and permissions
About this article
Cite this article
Anagrelide. Reactions Weekly 1862, 46 (2021). https://doi.org/10.1007/s40278-021-98164-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-98164-6